Vitrakvi (larotrectinib sulfate)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vitrakvi (larotrectinib sulfate), covering 2026-03-11 to 2026-03-11. Get the full timeline:
Most recent: EMA Authorised: Vitrakvi (larotrectinib sulfate) — Bayer AG